Pirouette Pharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Crowdfunding
  • (Announced)

  • Latest Deal Amount
  • $4.97M

  • Investors
  • 20

Pirouette Pharma General Information

Description

Developer of automated injectors designed for the emergency treatment of severe allergic reactions. The company's injectors are portable and intuitive and address all the major pain points through a human-centered design that focuses on auto-injector places healthcare in the hands of the patient, where the improved patient experience is built on increased access, enabling healthcare industries to diversely apply drugs that require fixed-dose, single-use intramuscular or subcutaneous injections.

Contact Information

Website
www.pirouettepharma.com
Formerly Known As
Pirouette Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 International Drive
  • Suite 170-180
  • Portsmouth, NH 03801
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 200 International Drive
  • Suite 170-180
  • Portsmouth, NH 03801
  • United States
+1 (617)

Pirouette Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pirouette Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Equity Crowdfunding 09-Feb-2026 $4.97M Announced Generating Revenue
6. Later Stage VC 18-Mar-2026 Completed Generating Revenue
5. Equity Crowdfunding 20-Feb-2025 Completed Generating Revenue
4. Later Stage VC 01-Jul-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 02-Sep-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2021 $125K $125K Completed Generating Revenue
1. Grant 02-May-2018 $25K Completed Generating Revenue
To view Pirouette Pharma’s complete valuation and funding history, request access »

Pirouette Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-5
Series A-4
Series A-3
Series A-2 468,793 $0.000010 $0.96 $0.96 1x $0.96 2.45%
Series A-1 1,288,640 $0.000010 $0.87 $0.87 1x $0.87 6.74%
To view Pirouette Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Pirouette Pharma Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Pirouette Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10441714-B2 Protective case for an auto-injector Active 05-Oct-2017
US-11324882-B2 Protective case for an auto-injector Active 05-Oct-2017
US-12527910-B2 Protective case for an auto-injector Active 05-Oct-2017
US-20190105442-A1 Protective case for an auto-injector Active 05-Oct-2017
US-20200016330-A1 Protective case for an auto-injector Active 05-Oct-2017 A61M5/14248
To view Pirouette Pharma’s complete patent history, request access »

Pirouette Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pirouette Pharma Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Titan Holdings Venture Capital Minority
Founders, Inc Venture Capital Minority
Gaingels Venture Capital Minority
Angel (individual)
Knockout Capital Hedge Fund
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

Pirouette Pharma FAQs

  • When was Pirouette Pharma founded?

    Pirouette Pharma was founded in 2017.

  • Where is Pirouette Pharma headquartered?

    Pirouette Pharma is headquartered in Portsmouth, NH.

  • What is the size of Pirouette Pharma?

    Pirouette Pharma has 29 total employees.

  • What industry is Pirouette Pharma in?

    Pirouette Pharma’s primary industry is Drug Discovery.

  • Is Pirouette Pharma a private or public company?

    Pirouette Pharma is a Private company.

  • What is Pirouette Pharma’s current revenue?

    The current revenue for Pirouette Pharma is .

  • How much funding has Pirouette Pharma raised over time?

    Pirouette Pharma has raised $22.9M.

  • Who are Pirouette Pharma’s investors?

    Titan Holdings, Founders, Inc, Gaingels, , and Knockout Capital are 5 of 20 investors who have invested in Pirouette Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process